(Q39225384)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10464834%20AND%20SRC:MED&resulttype=core&format=json

12 December 2019

title

Inhaled antibiotic therapy in non-cystic fibrosis patients with bronchiectasis and chronic bronchial infection by Pseudomonas aeruginosa (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10464834%20AND%20SRC:MED&resulttype=core&format=json

12 December 2019

main subject

cystic fibrosis

0 references

Pseudomonas aeruginosa

0 references

0 references

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10464834%20AND%20SRC:MED&resulttype=core&format=json

12 December 2019

Jordi Roig

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10464834%20AND%20SRC:MED&resulttype=core&format=json

12 December 2019

Antonio Vallano Ferraz

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10464834%20AND%20SRC:MED&resulttype=core&format=json

12 December 2019

author name string

J Ferrer

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10464834%20AND%20SRC:MED&resulttype=core&format=json

12 December 2019

G Sampol

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10464834%20AND%20SRC:MED&resulttype=core&format=json

12 December 2019

A Rosell

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10464834%20AND%20SRC:MED&resulttype=core&format=json

12 December 2019

A Ferrer

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10464834%20AND%20SRC:MED&resulttype=core&format=json

12 December 2019

publication date

1 July 1999

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10464834%20AND%20SRC:MED&resulttype=core&format=json

12 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10464834%20AND%20SRC:MED&resulttype=core&format=json

12 December 2019

volume

93

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10464834%20AND%20SRC:MED&resulttype=core&format=json

12 December 2019

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10464834%20AND%20SRC:MED&resulttype=core&format=json

12 December 2019

page(s)

476-480

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10464834%20AND%20SRC:MED&resulttype=core&format=json

12 December 2019

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2899%2990090-2

7 January 2021

Mucoid Pseudomonas aeruginosa is a marker of poor survival in cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2899%2990090-2

7 January 2021

Aerosol carbenicillin and gentamicin treatment of Pseudomonas aeruginosa infection in patients with cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2899%2990090-2

7 January 2021

Inhaled antibiotics in cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2899%2990090-2

7 January 2021

Nebulised colomycin for early pseudomonas colonisation in cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2899%2990090-2

7 January 2021

A controlled trial of nebulized aminoglycoside and oral flucloxacillin versus placebo in the outpatient management of children with cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2899%2990090-2

7 January 2021

Inhaled ceftazidime compared with gentamicin and carbenicillin in older patients with cystic fibrosis infected with Pseudomonas aeruginosa

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2899%2990090-2

7 January 2021

Colistin inhalation therapy in cystic fibrosis patients with chronic Pseudomonas aeruginosa lung infection

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2899%2990090-2

7 January 2021

Long-term tobramycin aerosol therapy in cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2899%2990090-2

7 January 2021

Safety of aerosol tobramycin administration for 3 months to patients with cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2899%2990090-2

7 January 2021

Long-term effects of inhaled tobramycin in patients with cystic fibrosis colonized with Pseudomonas aeruginosa.

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2899%2990090-2

7 January 2021

Efficacy of aerosolized tobramycin in patients with cystic fibrosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2899%2990090-2

7 January 2021

Nebulised antipseudomonal antibiotic therapy in cystic fibrosis: a meta-analysis of benefits and risks

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2899%2990090-2

7 January 2021

Clinical, pathophysiologic, and microbiologic characterization of bronchiectasis in an aging cohort

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2899%2990090-2

7 January 2021

Effect of sputum bacteriology on the quality of life of patients with bronchiectasis.

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2899%2990090-2

7 January 2021

Lung function in bronchiectasis: the influence of Pseudomonas aeruginosa.

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2899%2990090-2

7 January 2021

Nebulisers for bronchiectasis

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2899%2990090-2

7 January 2021

Cystic fibrosis in Spain: high frequency of mutation G542X in the Mediterranean coastal area

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2899%2990090-2

7 January 2021

Evaluation of two commercial jet nebulisers and three compressors for the nebulisation of antibiotics

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2899%2990090-2

7 January 2021

Bacterial infection in chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2899%2990090-2

7 January 2021

Epidemiological typing of Pseudomonas aeruginosa

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2899%2990090-2

7 January 2021

Pseudomonas aeruginosa adherence to remodelling respiratory epithelium

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2899%2990090-2

7 January 2021